Search by Drug Name or NDC

    NDC 62135-0732-60 Glipizide and metformin hcl 2.5; 500 mg/1; mg/1 Details

    Glipizide and metformin hcl 2.5; 500 mg/1; mg/1

    Glipizide and metformin hcl is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is GLIPIZIDE; METFORMIN HYDROCHLORIDE.

    Product Information

    NDC 62135-0732
    Product ID 62135-732_03aeed00-200f-0b57-e063-6394a90a8b47
    Associated GPIs
    GCN Sequence Number 051195
    GCN Sequence Number Description glipizide/metformin HCl TABLET 2.5-500 MG ORAL
    HIC3 C4S
    HIC3 Description ANTIHYPERGLYCEMIC,INSULIN-RELEASE STIM.-BIGUANIDE
    GCN 18367
    HICL Sequence Number 024429
    HICL Sequence Number Description GLIPIZIDE/METFORMIN HCL
    Brand/Generic Generic
    Proprietary Name Glipizide and metformin hcl
    Proprietary Name Suffix n/a
    Non-Proprietary Name Glipizide and metformin hcl
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 2.5; 500
    Active Ingredient Units mg/1; mg/1
    Substance Name GLIPIZIDE; METFORMIN HYDROCHLORIDE
    Labeler Name Chartwell RX, LLC
    Pharmaceutical Class Biguanide [EPC], Biguanides [CS], Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078728
    Listing Certified Through 2024-12-31

    Package

    NDC 62135-0732-60 (62135073260)

    NDC Package Code 62135-732-60
    Billing NDC 62135073260
    Package 60 TABLET, FILM COATED in 1 BOTTLE (62135-732-60)
    Marketing Start Date 2023-08-15
    NDC Exclude Flag N
    Pricing Information N/A